1-117881820-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP3BP6_ModerateBS2
The NM_017686.4(GDAP2):c.1302+3A>G variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00263 in 1,497,244 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 12 hom. )
Consequence
GDAP2
NM_017686.4 splice_donor_region, intron
NM_017686.4 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.9974
2
Clinical Significance
Conservation
PhyloP100: 1.65
Genes affected
GDAP2 (HGNC:18010): (ganglioside induced differentiation associated protein 2) Predicted to act upstream of or within response to retinoic acid. Located in lysosomal membrane. Implicated in autosomal recessive spinocerebellar ataxia 27. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 1-117881820-T-C is Benign according to our data. Variant chr1-117881820-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2639033.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDAP2 | NM_017686.4 | c.1302+3A>G | splice_donor_region_variant, intron_variant | ENST00000369443.10 | NP_060156.1 | |||
GDAP2 | NM_001135589.3 | c.1302+3A>G | splice_donor_region_variant, intron_variant | NP_001129061.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDAP2 | ENST00000369443.10 | c.1302+3A>G | splice_donor_region_variant, intron_variant | 2 | NM_017686.4 | ENSP00000358451 | P1 | |||
GDAP2 | ENST00000369442.3 | c.1302+3A>G | splice_donor_region_variant, intron_variant | 1 | ENSP00000358450 | |||||
GDAP2 | ENST00000491626.5 | n.308+3A>G | splice_donor_region_variant, intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00186 AC: 283AN: 152198Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
283
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00196 AC: 491AN: 250690Hom.: 2 AF XY: 0.00187 AC XY: 253AN XY: 135484
GnomAD3 exomes
AF:
AC:
491
AN:
250690
Hom.:
AF XY:
AC XY:
253
AN XY:
135484
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00271 AC: 3649AN: 1344928Hom.: 12 Cov.: 22 AF XY: 0.00263 AC XY: 1779AN XY: 675896
GnomAD4 exome
AF:
AC:
3649
AN:
1344928
Hom.:
Cov.:
22
AF XY:
AC XY:
1779
AN XY:
675896
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00186 AC: 283AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.00168 AC XY: 125AN XY: 74482
GnomAD4 genome
AF:
AC:
283
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
125
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
GDAP2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 28, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | GDAP2: BP4, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at